HK1042699A1 - N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists. - Google Patents

N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.

Info

Publication number
HK1042699A1
HK1042699A1 HK02104096A HK02104096A HK1042699A1 HK 1042699 A1 HK1042699 A1 HK 1042699A1 HK 02104096 A HK02104096 A HK 02104096A HK 02104096 A HK02104096 A HK 02104096A HK 1042699 A1 HK1042699 A1 HK 1042699A1
Authority
HK
Hong Kong
Prior art keywords
triazolylmethyl
receptor antagonists
piperazine derivatives
neurokinin receptor
neurokinin
Prior art date
Application number
HK02104096A
Other languages
English (en)
Inventor
Daniel Jasserand
Uwe Schon
Holger Sann
Reinhard Bruckner
Christian Eeckhout
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1042699A1 publication Critical patent/HK1042699A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK02104096A 2000-07-28 2002-05-31 N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists. HK1042699A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
HK1042699A1 true HK1042699A1 (en) 2002-08-23

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104096A HK1042699A1 (en) 2000-07-28 2002-05-31 N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.

Country Status (28)

Country Link
US (1) US6407106B1 (xx)
EP (1) EP1176144B1 (xx)
JP (1) JP2002053577A (xx)
KR (1) KR100924405B1 (xx)
CN (1) CN1167698C (xx)
AR (1) AR028743A1 (xx)
AT (1) ATE244716T1 (xx)
AU (1) AU779318B2 (xx)
BR (1) BR0103048A (xx)
CA (1) CA2354213C (xx)
CZ (1) CZ301695B6 (xx)
DE (2) DE10036818A1 (xx)
DK (1) DK1176144T3 (xx)
DZ (1) DZ3119A1 (xx)
ES (1) ES2201007T3 (xx)
HK (1) HK1042699A1 (xx)
HU (1) HU226687B1 (xx)
IL (1) IL144299A (xx)
IN (1) IN191021B (xx)
NO (1) NO323233B1 (xx)
NZ (1) NZ513041A (xx)
PL (1) PL210436B1 (xx)
PT (1) PT1176144E (xx)
RU (1) RU2288918C2 (xx)
SK (1) SK284802B6 (xx)
TW (1) TWI304403B (xx)
UA (1) UA73728C2 (xx)
ZA (1) ZA200105737B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
BR0309486A (pt) * 2002-04-26 2005-02-09 Lilly Co Eli Composto ou um seu sal farmaceuticamente aceitável, composição farmacêutica, e, método para o tratamento de uma condição associada com um excesso de taquicininas
UA79113C2 (en) * 2002-04-26 2007-05-25 Lilly Co Eli Triazole derivatives as tachykinin receptor antagonists
EP1638944A1 (en) * 2003-06-12 2006-03-29 Eli Lilly And Company Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
EP1910316B1 (en) * 2005-07-25 2010-11-10 F. Hoffmann-La Roche AG Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
JP2010516734A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド ３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジンまたはｒ（−）−２，４−ジアミノ−５−（２，３−ジクロロフェニル）−６−フルオロメチルピリミジンを含む医薬組成物
WO2011020874A1 (en) 2009-08-20 2011-02-24 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
NO2729147T3 (xx) 2011-07-04 2018-02-03
CN111918647A (zh) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 用于治疗眼痛的nk-1拮抗剂
US20230134843A1 (en) 2020-03-11 2023-05-04 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
AU706021B2 (en) * 1995-05-25 1999-06-03 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
US6087357A (en) * 1995-12-18 2000-07-11 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives as tachykinin antagonists
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
EP0899270B1 (de) * 1997-08-27 2008-05-21 Solvay Pharmaceuticals GmbH Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
DE19824865A1 (de) * 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Also Published As

Publication number Publication date
AU5767501A (en) 2002-01-31
HU0102931D0 (en) 2001-09-28
IL144299A0 (en) 2002-05-23
EP1176144A1 (de) 2002-01-30
BR0103048A (pt) 2002-04-02
CN1167698C (zh) 2004-09-22
PL348946A1 (en) 2002-02-11
RU2288918C2 (ru) 2006-12-10
CN1335316A (zh) 2002-02-13
CZ301695B6 (cs) 2010-05-26
DK1176144T3 (da) 2003-10-27
AR028743A1 (es) 2003-05-21
ATE244716T1 (de) 2003-07-15
AU779318B2 (en) 2005-01-13
JP2002053577A (ja) 2002-02-19
KR100924405B1 (ko) 2009-10-29
CZ20011813A3 (cs) 2002-03-13
IN191021B (xx) 2003-09-13
CA2354213C (en) 2010-04-27
US20020065276A1 (en) 2002-05-30
HUP0102931A3 (en) 2003-07-28
NO20013709D0 (no) 2001-07-27
US6407106B1 (en) 2002-06-18
NZ513041A (en) 2002-12-20
PL210436B1 (pl) 2012-01-31
CA2354213A1 (en) 2002-01-28
NO323233B1 (no) 2007-02-05
KR20020010482A (ko) 2002-02-04
ZA200105737B (en) 2002-01-22
SK284802B6 (sk) 2005-11-03
DE10036818A1 (de) 2002-02-07
DZ3119A1 (fr) 2004-09-19
IL144299A (en) 2004-08-31
NO20013709L (no) 2002-01-29
HU226687B1 (en) 2009-06-29
UA73728C2 (en) 2005-09-15
HUP0102931A2 (hu) 2002-11-28
TWI304403B (en) 2008-12-21
PT1176144E (pt) 2003-11-28
ES2201007T3 (es) 2004-03-16
EP1176144B1 (de) 2003-07-09
DE50100358D1 (de) 2003-08-14
SK7572001A3 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
MXPA03001143A (es) Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina-1.
ZA200204395B (en) Selective neurokinin antagonists.
MXPA03002907A (es) Antagonistas receptores metabotropicos de glutamato.
EP1349839B8 (en) Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
HK1058360A1 (en) 4-Phenyl-pyridine derivatives as neurokinin-1 receptor antagonists.
MXPA03000738A (es) Antagonistas de grelina.
ZA200408670B (en) Trizole derivatives as tachykinin receptor antagonists.
AU6751301A (en) 1,3,8-triaza-spiro'4,5]decan-4-one derivatives as neurokinin receptor antagonists
PL365377A1 (en) Amide derivatives as nmda receptor antagonists
HK1084394A1 (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use for preparing neurokinin antagonists
HK1039330A1 (en) Piperidine derivatives useful as ccr5 antagonists.
ZA991413B (en) Substituted quinoxaline derivatives as interleukin-8 receptor antagonists.
HK1046909A1 (en) Piperazine derivatives as 5-ht1b antagonists.
MXPA03006991A (es) Derivados de piperidina como antagonistas de neurocinina 1.
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HK1051863A1 (en) Indol-3-yl derivatives.
HK1042699A1 (en) N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.
MXPA03004652A (es) Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato.
HK1045684A1 (en) Biphenyl derivatives as antagonists of the neurokinine-1 receptor.
ZA200201789B (en) Substituted pyrrolidin-2,3,4-trion-3-oxime drivatives useful as NMDA-receptor antagonists.
MXPA03003892A (es) Antagonistas del receptor bombesin.
HK1052925A1 (en) Substituted 1-aminobutan-3-ol derivatives.
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
EP1351687A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
AU2673201A (en) Alpha-arylethylpiperazine derivatives as neurokinin antagonists

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120710